Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 14, which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 14 average citations.

Following are the list of articles that have cited the articles published in Advances in Pharmacoepidemiology and Drug Safety.

  2022 2021 2020 2019 2018

Year wise published articles

30 32 23 3 4

Year wise citations received

71 95 59 87 69
Journal total citations count 654
Journal Impact Factor 2.86
Journal 5 years Impact Factor 4.33
Journal CiteScore 5.34
Journal h-index 14
Important citations

Patil JS (2015) Novel Tubercular Therapeutic Agents: Need of the Day. Adv Pharmacoepidemiol Drug Saf  4: e137.

Prakash J, Joshi K, Malik D, Mishra O, Sachan A, Kumar B, Bhushan S, Kalaiselvan V, Singh GN. “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India. Indian journal of pharmacology. 2019 Jul;51(4):236.

Li L, Wang J, Zang H, Zhang H, Jiang W, et al. (2016) Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Kalaiselvan V, Thota P, Singh GN (2016) Pharmacovigilance Programme of India: Recent developments and future perspectives. Indian Journal of Pharmacology, 48: 624.

Singh P, Agrawal M, Hishikar R, Joshi U, Maheshwari B, Halwai A. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Indian journal of pharmacology. 2017 Nov;49(6):432.

Nole T, Evariste F, Adamou B, Bernard D, Nehemie DT, Alembert TT, Gabriel A, Francois Z, Benoit NT. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. alcoholism.;5:6.

Sultana S. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Prejbisz A, Klocek M, GÄ…sowski J, Topór-MÄ…dry R, LeÅ›niak W, et al. (2015) Trends for beta-blockers use in a large cohort of Polish hypertensive patients—Pol-Fokus Study. Arterial Hypertension, 19: 120-128.

Yang R, Luo Z, Liu Y, Sun M, Zheng L, et al. (2016) Drug interactions with angiotensin receptor blockers: role of human cytochromes P450. Current drug metabolism, 17: 681-691.

Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S et al (2016) A review on prescribing patterns of antihypertensive drugs. Clinical hypertension 22: 7.

Kostovski V, Dukovska I, Aleksovska IT, Kuzmanovski A, Dimkoska S, Crcarovska M, Vukikjevikj N. Implementation of the new EMA methodology of defining risks and the HaRP methodology in the EU Risk Management Plan for Ibuprofen 40 mg/mL oral suspension.

Sawarkar A, Sharma RK, Gautam V, Shramankar K, Dinodia N. Pharmacovigilance: Present status and future perspectives. The Pharma Innovation Journal. 2019;8(8):84-92.

Srividya B (2016) Drugs Acting on Blood Coagulation system and their Mechanism of Action: A review.

Anand N (2016) Research & Reviews: Journal of Medical and Health Sciences.

García-Cortés M, Robles-Díaz M, Ortega-Alonso A, Medina-Caliz I, & Andrade RJ (2016) Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. International journal of molecular sciences, 17: 537.

Mazzanti G, Di Sotto A, & Vitalone A (2015) Hepatotoxicity of green tea: an update. Archives of toxicology 89: 1175-1191.

Eh K, McGill M, Wong J & Krass I (2016) Cultural issues and other factors that affect self-management of Type 2 Diabetes Mellitus (T2D) by Chinese immigrants in Australia. Diabetes Research and Clinical Practice 119: 97-105.

Adegbola SA, Marincowitz GJ, Govender I, & Ogunbanjo GA (2016) Assessment of self-reported adherence among patients with type 2 diabetes in Matlala District Hospital, Limpopo Province: original research. African Journal of Primary Health Care and Family Medicine 8: 1-5.

Shabana MD (2016) Research and Reviews: Journal of Pharmacology and Toxicological Studies.

Prasad VGN, Achanta S, Tammineni YR, Alla GR, Thirtham MR, et al. (2016) Effect of multi drug resistance protein 4 (MRP4) inhibition on the pharmacokinetics and pharmacodynamics of ciprofloxacin in normal and rats with LPS-induced inflammation. European journal of drug metabolism and pharmacokinetics 41: 733-741.